Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 226,748 | 168,027 | 171,806 | 294,150 | 523,506 |
| Marketable Securities | 685,475 | 686,761 | 736,268 | 639,392 | 669,116 |
| Receivables | 36,456 | 6,491 | 5,056 | 4,906 | 3,768 |
| TOTAL | $998,330 | $893,493 | $939,615 | $963,671 | $1,216,797 |
| Non-Current Assets | |||||
| PPE Net | 32,760 | 33,800 | 33,194 | 31,606 | 27,921 |
| Investments And Advances | 111,629 | 154,918 | 185,850 | 253,427 | 101,793 |
| Other Non-Current Assets | 158,258 | 161,138 | 164,581 | 169,185 | 173,603 |
| TOTAL | $302,647 | $349,856 | $383,625 | $454,218 | $303,317 |
| Total Assets | $1,300,977 | $1,243,349 | $1,323,240 | $1,417,889 | $1,520,114 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,452 | 3,553 | 11,634 | 6,890 | 5,154 |
| Accrued Expenses | 67,017 | 57,979 | 49,534 | 44,822 | 60,876 |
| TOTAL | $115,208 | $91,953 | $99,851 | $103,383 | $126,554 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 22,140 | 13,347 | 21,933 | 35,343 | 43,839 |
| Other Non-Current Liabilities | 96,747 | 101,263 | 105,582 | 109,801 | 138,044 |
| TOTAL | $135,600 | $113,982 | $118,501 | $123,663 | $157,976 |
| Total Liabilities | $250,808 | $205,935 | $218,352 | $227,046 | $284,530 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 96,106 | 89,555 | 88,491 | 88,141 | 88,018 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -1,658,379 | -1,526,218 | -1,403,994 | -1,280,313 | -1,177,187 |
| Other shareholders' equity | -2,258 | -3,572 | -3,868 | -2,678 | -7,461 |
| TOTAL | $1,050,169 | $1,037,414 | $1,104,888 | $1,190,843 | $1,235,584 |
| Total Liabilities And Equity | $1,300,977 | $1,243,349 | $1,323,240 | $1,417,889 | $1,520,114 |